Abstract
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting, members were updated on several ongoing activities during the key project update session. These activities included the Biomarker Project, the Axial Psoriatic Arthritis Molecular and Clinical Characterization study, the Diagnostic Ultrasound Enthesitis Tool (DUET) study, the Sex- and Gender-Based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis (SAGE-PsA) study, the Early Recognition of PsA (COMPOSITION) study, and the GRAPPA treatment recommendations.
- Accepted for publication August 4, 2025.
- Copyright © 2025 by The Journal of Rheumatology
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
Jump to section
- Article
- Abstract
- Biomarker Project, by Dr. Vinod Chandran
- Axial Psoriatic Arthritis Molecular and Clinical Characterization study, by Dr. Philip Mease
- Diagnostic Ultrasound Enthesitis Tool study, by Drs. Lihi Eder, Sibel Aydin, and Gurjit Kaeley
- Sex- and Gender-Based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis, by Dr. Lihi Eder
- Early Recognition of PsA (COMPOSITION) study, by Dr. Denis Poddubnyy
- GRAPPA treatment recommendations update, by Drs. Arthur Kavanaugh, Enrique Soriano, Laura Coates, Ennio Lubrano, Ying Ying Leung, Suzanne Grieb, and Lourdes Perez-Chada
- Conclusion
- ACKNOWLEDGMENT
- Footnotes
- REFERENCES
- Info & Metrics
- References